US Patent Issued to Arena Pharmaceuticals on Feb. 24 for "Pyrimidine derivatives as modulators of the 5-HT 2A serotonin receptor useful for the treatment of disorders related thereto" (California Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,462, issued on Feb. 24, was assigned to Arena Pharmaceuticals Inc. (New York).

"Pyrimidine derivatives as modulators of the 5-HT 2A serotonin receptor useful for the treatment of disorders related thereto" was invented by Graeme Semple (San Diego) and Thuy-Anh Tran (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a compound of Formula (I) or a pharmaceutically acceptable salt thereof, that is a modulator of 5-HT2A and can be used in treating diseases and disorders associated with 5-HT2A serotonin receptor expression and/or activity. Thus, also provided are methods of treating 5HT2A-related diseases and disorders."

The patent wa...